Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
38,512,859
-
Total 13F shares
-
24,001,384
-
Share change
-
-69,718
-
Total reported value
-
$33,602,029
-
Price per share
-
$1.40
-
Number of holders
-
37
-
Value change
-
-$48,851
-
Number of buys
-
10
-
Number of sells
-
13
Institutional Holders of Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) as of Q1 2024
As of 31 Mar 2024,
Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,001,384 shares.
The largest 10 holders included
Vivo Capital, LLC, TANG CAPITAL MANAGEMENT LLC, Sofinnova Investments, Inc., CITADEL ADVISORS LLC, Pivotal bioVenture Partners Investment Advisor LLC, Newtyn Management, LLC, ORBIMED ADVISORS LLC, Nan Fung Group Holdings Ltd, Samsara BioCapital, LLC, and VANGUARD GROUP INC.
This page lists
37
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.